Shares of ProMetic Life Sciences Inc. (TSE:PLI – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$13.60 and traded as high as C$13.72. ProMetic Life Sciences shares last traded at C$13.60, with a volume of 921 shares traded.
ProMetic Life Sciences Price Performance
The company has a market capitalization of C$317.06 million and a price-to-earnings ratio of -0.22. The company has a debt-to-equity ratio of 37.47, a quick ratio of 3.66 and a current ratio of 4.06. The business has a 50-day moving average price of C$13.60.
About ProMetic Life Sciences
Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals.
Featured Articles
- Five stocks we like better than ProMetic Life Sciences
- What Are Dividend Achievers? An Introduction
- Should You Invest in Treasury Bills?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Receive News & Ratings for ProMetic Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMetic Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
